Value Sense
KVUE
Kenvue Inc. (KVUE)
Last Price$23.80.8%
Market Cap$45.5B
Intrinsic value score
6/10
Good
Intrinsic value
$21.1
DCF value - $16.6 Relative value - $25.6
Overvalued
11.3%
LTM P/E
44.2x
Peer set median 35.3x
Discount rate
8.6%
KVUE
is 11.3% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

KVUE Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 KVUE Relative Value is $25.7, which is undervalued by 7.9%, compared to current share price of $23.8.
DCF Value vs Current Share Price
As of Mar 03, 2025 KVUE DCF Value is $16.4, which is overvalued by 31.1%, compared to current share price of $23.8.
Methodology
Price per share, $
KVUE
Intrinsic value$21.1
Overvalued by11.3%
Current share price
23.8
Relative value
25.7
DCF value
16.4

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

KVUE Historical Intrinsic Value

Crunching data... Almost there!

KVUE vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Kenvue Inc. logo
Kenvue Inc.KVUE
(11.3%)
0.1%
(40.0%)
6.7%
Median Peer Set
2.9%
(4.3%)
10.2%
Hims & Hers Health, Inc. logo
Hims & Hers Health, Inc.HIMS
(45.4%)
65.5%
(65.6%)
(2.7%)
Church & Dwight Co., Inc. logo
Church & Dwight Co., Inc.CHD
(28.8%)
4.1%
(22.7%)
9.6%
The Clorox Company logo
The Clorox CompanyCLX
(24.8%)
(4.0%)
86.0%
3.9%
The Procter & Gamble Company logo
The Procter & Gamble CompanyPG
(22.6%)
2.5%
3.8%
17.7%
Colgate-Palmolive Company logo
Colgate-Palmolive CompanyCL
(10.2%)
3.3%
27.0%
14.4%
e.l.f. Beauty, Inc. logo
e.l.f. Beauty, Inc.ELF
0.4%
76.9%
99.1%
12.5%
Kimberly-Clark Corporation logo
Kimberly-Clark CorporationKMB
11.6%
(1.8%)
45.5%
12.7%
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
33.4%
(1.9%)
(61.2%)
2.5%
Unilever PLC logo
Unilever PLCUL
57.2%
1.8%
(12.4%)
10.9%
Coty Inc. logo
Coty Inc.COTY
182.3%
10.2%
(85.0%)
1.5%

Explore more intrinsic value tools hub for KVUE

Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value

FAQ

What is Kenvue Inc. intrinsic value?

As of Mar 03, 2025, Kenvue Inc. Intrinsic Value is $21.1. This suggests it may be overvalued by 11.3% compared to its current price of around $23.8.

What is Kenvue Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Kenvue Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $16.4. This suggests it may be overvalued by 31.1% to its current price of around $23.8, using a discount rate of 8.6% and terminal growth rate of 2.0%.

Is Kenvue Inc. overvalued or undervalued?

Kenvue Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $21.1, compared to a market price of around $23.8. This suggests a potential overvaluation of 11.3%.